In the present study, the results demonstrated that
P. gingivalis increased c-Myc and decreased p53 gene expression in DPS-7 cell lines, supporting the hypothesis that exposure to
P. gingivalis may induce molecular alterations associated with carcinogenesis-related pathways. The association between compositional changes in oral bacteria and OSCC, as well as the mechanisms by which oral bacteria influence oral cancer progression, is a critical area for identifying potential strategies for early diagnosis and effective treatment. Therefore, the results of the present study indicate that
P. gingivalis may play a role in oral cancer development and could serve as a basis for future clinical development of preventive, early diagnostic, and therapeutic protocols. Several studies have suggested that repeated exposure of cells to
P. gingivalis can lead to cancer, especially in the orodigestive system (
11-
13). Therefore, DPS-7 cells were exposed to
P. gingivalis for a continuous 42-hour incubation period to evaluate the molecular response to bacterial exposure and detect the carcinogenic effect of this bacterium. Notably,
P. gingivalis uses lipid microdomains of the target cell membrane and cytoskeletal functions to facilitate its internalization into cells (
14). Because two ribosomal bands, 18S rRNA and 28S rRNA, are associated with DPS-7 cells, whereas two bands, 16S rRNA and 23S rRNA, are associated with
P. gingivalis, the presence of all four ribosomal bands in the P.DPS-7 group suggested bacterial association with the exposed DPS-7 cells. This finding suggests the involvement of
P. gingivalis in oral cancer progression and indicates increased oncogene expression and decreased tumor suppressor gene expression in
P. gingivalis-infected DPS-7 cells.
To the best of our knowledge, these findings suggest that
P. gingivalis may contribute to molecular changes associated with oral carcinogenesis. Although the association of
P. gingivalis with OSCC and other orodigestive cancers has been frequently reported, several mechanisms have been suggested in cellular and clinical studies (
11,
12). Most studies have suggested that prolonged exposure to
P. gingivalis not only contributes to oral cancer through chronic inflammation but also promotes cancer migration and invasiveness and induces resistance to chemotherapy. This has been documented through the upregulation of matrix metalloproteinases (MMPs-1 and MMPs-2d) and inflammatory cytokines such as interleukin-8 in OSC-20 and SAS cells (
15,
16). Geng and colleagues exposed human immortalized oral epithelial cells to
P. gingivalis and found that persistent exposure to the bacterium caused morphological changes, increased proliferative ability (higher S-phase fraction), enhanced cell migration, and promoted invasive properties, with multiple tumor-related genes identified as involved (
17,
18). These results are consistent with the findings of the present study regarding the associative role of
P. gingivalis in OSCC; however, none of the previous studies specifically focused on the two tumor suppressor genes and oncogenes examined here.
Other studies have investigated human and murine cells and pre-established cell lines to elucidate the mechanism of
P. gingivalis in OSCC. A review of studies indicated its role in three phases, including epithelial-mesenchymal transition of malignant cells, neoplastic proliferation, and tumor invasion through different mechanisms (
19). Another review highlighted mechanisms including sustained proliferative signaling through activation of the PI3K/AKT pathway; evasion of apoptosis through activation of the Jak/STAT, PI3K/AKT, and nucleoside diphosphate kinase pathways; evasion of growth suppressors by inactivating phosphatase and tensin homolog and p53; sustained angiogenesis through induction of vascular endothelial growth factor and Ephrin B2; avoidance of immune destruction through apoptosis of T and B cells; and invasion/metastasis by inducing epithelial-mesenchymal transition (
20).
Wild-type p53, known as the guardian of the genome, is a tumor suppressor protein that protects genomic integrity by regulating the cell cycle and controlling cell death genes in response to DNA damage. It is widely used as an important tumor marker in clinical practice across different cancers (
21). It has also been suggested as a useful marker for diagnosing premalignant lesions and OSCC and for predicting a poor prognosis in such patients (
22). Other studies have documented that suppression and downregulation of the guardian of the genome, p53, by any factor can lead to OSCC by blocking apoptosis and through other mechanisms (
23,
24). This finding is consistent with the present study, in which we provided evidence that
P. gingivalis is the contributing factor. Additional evidence supports the role of p53 in gingival epithelial cell progression. As determined in the review by Kuboniwa and colleagues,
P. gingivalis induced changes in the levels and phosphorylation of p53 and PI3K in gingival epithelial cells (
25), which is consistent with the results of the present study, although that review did not focus exclusively on OSCC.
Another important factor investigated in the present study was c-Myc, an oncoprotein and transcription factor that drives activating mutations in cancer-causing proteins. c-Myc is not only involved in tumor initiation and growth but also plays a critical role in tumor progression, proliferation, and invasion (
26). Studies on OSCC have also revealed that c-Myc overexpression significantly affects cell survival, proliferation, and tumor growth (
27). Among the various factors suggested to contribute to c-Myc overexpression or upregulation in OSCC pathogenesis,
P. gingivalis had not been previously evaluated; we documented this here for the first time. In another study, Mengand and colleagues reported that c-Myc was upregulated following stimulation of oral and esophageal squamous cell carcinoma with
P. gingivalis, which, along with NF-κB (P65) in the nucleus, showed the vital role of
P. gingivalis in the progression and development of esophageal squamous cell carcinoma.
The present study was novel in examining c-Myc and p53 in human-extracted DPS-7 cells after exposure to P. gingivalis, compared with E. coli and a control group. It demonstrated molecular alterations associated with carcinogenesis-related pathways following exposure to P. gingivalis. However, this study also had some limitations. We did not directly measure apoptosis using flow cytometry, but comparisons of apoptosis levels between contaminated and control groups could provide further insights. Additionally, including other bacteria, such as F. nucleatum, would have allowed a comparative assessment to determine which bacterial species exerted a greater influence on OSCC. In addition, intracellular bacterial viability and internalization were not directly confirmed using invasion assays, fluorescence microscopy, or antibiotic protection assays. Therefore, the observed gene-expression changes may reflect responses to bacterial exposure rather than exclusively intracellular bacterial activity. Finally, this was an in vitro study, and further in vivo studies in animal models, followed by clinical studies in humans, are required to reach definitive conclusions.
5.1. Conclusions
The present study demonstrated that exposure of DPS-7 dental pulp stem cells to P. gingivalis altered the expression of c-Myc and p53 genes, suggesting a possible role for this bacterium in molecular pathways associated with oral carcinogenesis. These findings help clinicians better understand the role of this oral microbiota in OSCC, an aggressive tumor, and provide a foundation for future studies investigating the clinical significance of this association. These findings may also provide a basis for future investigations exploring the relationship between oral microbiota and carcinogenesis-related molecular pathways.